These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36280399)
1. Addictovigilance in women, the hidden part of the iceberg? Lapeyre-Mestre M Therapie; 2023; 78(2):157-164. PubMed ID: 36280399 [TBL] [Abstract][Full Text] [Related]
2. [Involvement of addictovigilance in emergency department for the detection of abuse and dependence cases: 3 years of experience]. Serre A; Eiden C; Gourhant V; Laureau M; Perier D; Giraud I; Sebbane M; Peyrière H Therapie; 2018 Dec; 73(6):501-509. PubMed ID: 30017376 [TBL] [Abstract][Full Text] [Related]
3. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network? Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596 [TBL] [Abstract][Full Text] [Related]
4. Signal identification in addictovigilance: the functioning of the French system. Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A Therapie; 2015; 70(2):113-31. PubMed ID: 25858567 [TBL] [Abstract][Full Text] [Related]
5. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]. Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770 [TBL] [Abstract][Full Text] [Related]
6. Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J; Therapie; 2020; 75(4):343-354. PubMed ID: 32660776 [TBL] [Abstract][Full Text] [Related]
7. Use of new psychoactive substances to mimic prescription drugs: The trend in France. Batisse A; Eiden C; Peyriere H; Djezzar S; Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674 [TBL] [Abstract][Full Text] [Related]
8. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)]. Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700 [TBL] [Abstract][Full Text] [Related]
9. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M; Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399 [TBL] [Abstract][Full Text] [Related]
10. Sex/gender differences in spontaneous reports to a French Addictovigilance centre. Peyriére H; Dampierre A; Vallo R; Lestienne M; Eiden C; Donnadieu H Arch Womens Ment Health; 2024 Jul; ():. PubMed ID: 38980402 [TBL] [Abstract][Full Text] [Related]
11. [Use of synthetic substances in France and in Europe]. Debruyne D; Monzon E; Perino J; Haramburu F; Daveluy A; Lazès-Charmetant A; Giraudon I Therapie; 2021; 76(3):221-228. PubMed ID: 32859404 [TBL] [Abstract][Full Text] [Related]
12. Nitrous oxide: a unique official French addictovigilance national survey. Guerlais M; Aquizerate A; Lionnet A; Daveluy A; Duval M; Gérardin M; Istvan M; Laforgue EJ; Victorri-Vigneau C; Front Public Health; 2023; 11():1167746. PubMed ID: 37206871 [TBL] [Abstract][Full Text] [Related]
13. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution. Dupui M; Micallef J; Lapeyre-Mestre M Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951 [TBL] [Abstract][Full Text] [Related]
14. COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): a cross-sectional study in France. Batisse A; Leger S; Vicaut E; Gerbaud L; Djezzar S Public Health; 2021 May; 194():75-78. PubMed ID: 33865150 [TBL] [Abstract][Full Text] [Related]
15. [Psychoactive substance use during pregnancy: a review]. Lamy S; Thibaut F Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194 [TBL] [Abstract][Full Text] [Related]
16. [Twenty-five years of the French Addictovigilance Network (FAN)]. Micallef J; Mallaret M Therapie; 2016 Sep; 71(4):375-8. PubMed ID: 27296806 [TBL] [Abstract][Full Text] [Related]
17. [Acting out and psychoactive substances: alcohol, drugs, illicit substances]. Gillet C; Polard E; Mauduit N; Allain H Encephale; 2001; 27(4):351-9. PubMed ID: 11686057 [TBL] [Abstract][Full Text] [Related]
18. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey. Blayac L; Ponte C; Lavaud M; Micallef J; Lapeyre-Mestre M Therapie; 2023; 78(2):201-211. PubMed ID: 36283856 [TBL] [Abstract][Full Text] [Related]
19. [Psychoactive substances use in Réunion Island and Mayotte, French departments in Indian Ocean]. Daveluy A; Haramburu F Therapie; 2018 Oct; 73(5):419-427. PubMed ID: 29773359 [TBL] [Abstract][Full Text] [Related]
20. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)]. Baumevieille M; Perri-Plandé J; Miremont-Salamé G; Daveluy A; Haramburu F Therapie; 2019 Jun; 74(3):375-382. PubMed ID: 30193805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]